Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell wall anionic polymers, primarily comprising wall teichoic acids (WTA) and lipoteichoic acids (LTA), are essential glycopolymers found in the cell walls of Gram-positive bacteria [Brown et al., 2013, Nature Reviews Microbiology]. These polymers play critical roles in maintaining cell wall integrity, regulating ion homeostasis by sequestering magnesium ions, and mediating bacterial interactions with the host environment, including adhesion and biofilm formation [Swoboda et al., 2010, ChemBioChem]. Because they are vital for bacterial survival and virulence but absent in mammalian cells, they represent attractive targets for novel antimicrobial agents [Campbell et al., 2011, ACS Chemical Biology]. Drugs targeting these polymers, such as teixobactin or experimental inhibitors of the TarO and TarG enzymes, work by disrupting the synthesis or assembly of the cell wall, leading to bacterial lysis or increased susceptibility to host immune defenses [Ling et al., 2015, Nature]. Furthermore, LTA is a known potent inducer of the host inflammatory response through its interaction with Toll-like receptor 2 (TLR2), making its management crucial in treating systemic infections like sepsis [Schirner et al., 2009, Journal of Biological Chemistry]. The development of resistance to these agents often involves complex genetic rearrangements in the biosynthetic pathways, such as D-alanylation, which presents a significant therapeutic challenge [Winstel et al., 2014, International Journal of Medical Microbiology].
Inhibition of biosynthesis (e.g., TarO or TarG inhibition), binding to lipid-linked precursors such as Lipid III (e.g., Teixobactin), and disruption of membrane-anchored polymer stability (e.g., Daptomycin) [Ling et al., 2015, Nature; Swoboda et al., 2009, Science].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall anionic polymer (WTA/LTA).